A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
Clinical trial NCT05147558 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05147558
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2026-12-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.